Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Biogen Inc    BIIB

BIOGEN INC (BIIB)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/17/2017 04/18/2017 04/19/2017 04/20/2017 04/21/2017 Date
274.05(c) 271.16(c) 271.94(c) 272.46(c) 272.94(c) Last
1 025 839 1 379 501 1 190 333 981 158 1 122 424 Volume
+0.80% -1.05% +0.29% +0.19% +0.18% Change
More quotes
Financials ($)
Sales 2017 11 261 M
EBIT 2017 6 073 M
Net income 2017 3 962 M
Debt 2017 52,3 M
Yield 2017 -
Sales 2018 11 938 M
EBIT 2018 6 315 M
Net income 2018 4 407 M
Finance 2018 2 683 M
Yield 2018 -
P/E ratio 2017 14,82
P/E ratio 2018 13,17
EV / Sales2017 5,24x
EV / Sales2018 4,71x
Capitalization 58 942 M
More Financials
Company
Biogen, Inc. is a global biotechnology company, which focuses on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders.Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for... 
Sector
Pharmaceuticals
Calendar
07/27Earnings Release
More about the company
Surperformance© ratings of Biogen Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOGEN INC
04/21 BIOGEN : SPINRAZA® (nusinersen) Receives Positive CHMP Opinion for the Treatment..
04/18 BIOGEN : Highlights Advances from Its Neurology Research Programs and Portfolio ..
03/28 BIOGEN : to Present Data at the 13th International Conference on Alzheimer&rsquo..
03/27 BIOGEN : to Report First Quarter 2017 Financial Results on April 25, 2017
03/16 BIOGEN : Appoints Anirvan Ghosh Senior Vice President, Research and Early Develo..
03/01 BIOGEN : Biotech Stocks Under Scanner -- Immunomedics, Peregrine Pharma, Vericel..
02/28 BIOGEN : to Present at the Cowen & Company 37th Annual Health Care Conference
02/15 BIOGEN : to Present at the 2017 RBC Capital Markets Global Healthcare Conference
02/07 BIOGEN : to Present at the Leerink Partners 6th Annual Global Healthcare Confere..
02/02 BIOGEN INC : Spin off
More news
Sector news : Biopharmaceuticals
04/21DJFDA OKs Samsung Bioepis's biosimilar version of J&J's Remicade
04/21 Teva's new asthma inhaler poses first competition for GSK's Advair
04/19DJSHIRE : Files 8K - Other Events
04/19DJFARON PHARMACEUTICALS OY : Appoints Two Non-Executive Directors
04/18 Johnson & Johnson first quarter revenue misses estimates; new forecast includ..
More sector news : Biopharmaceuticals
4-Traders Strategies on BIOGEN INC 
2014Back on a stimulating support
2013The bullish trend is not over
More Strategies
Latest Tweets
12:10aCoincidence $BIIB R&D chief brings up $SAGE data?
8
12:03aBiogen is back, and ready to make some deals
15
04/21$BIIB: Biogen confirms that the Committee for Medicinal Products for Human Us.. 
04/21Biogen's back! https://t.co/cTRl6heupQ Paging Slim Shady:
1
04/21Upcoming #earnings conference calls, webcasts  
More tweets
Qtime:125
News from SeekingAlpha
04/21 EMA hands down a number of recommendations
04/19 Gilead Sciences Near 3-Year Low. Time To Buy?
04/18 For $300M, Biogen Beefs Up Its Alzheimer's Attack
04/17 MAYBE THE WORLD SHOULD SPEND MORE ON : Implications
04/17 WALL STREET BREAKFAST : Geopolitical Concerns Weigh On Markets
Advertisement
Chart BIOGEN INC
Duration : Period :
Biogen Inc Technical Analysis Chart | BIIB | US09062X1037 | 4-Traders
Full-screen chart
Technical analysis trends BIOGEN INC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 313 $
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michel Vounatsos Chief Executive Officer & Director
Stelios B. Papadopoulos Chairman
Paul J. Clancy Chief Financial Officer & Executive Vice President
Alfred W. Sandrock Chief Medical Officer & Executive Vice President
Spyridon Artavanis-Tsakonas Chief Scientific Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOGEN INC4.44%58 942
CSL LIMITED27.42%43 947
ALEXION PHARMACEUTICAL..-4.52%26 302
GRIFOLS SA25.00%16 002
BIOMARIN PHARMACEUTICA..6.80%15 293
CHONGQING ZHIFEI BIOLO..--.--%4 539
More Results